دورية أكاديمية

Homocysteinemia and early outcome of acute ischemic stroke in elderly patients.

التفاصيل البيبلوغرافية
العنوان: Homocysteinemia and early outcome of acute ischemic stroke in elderly patients.
المؤلفون: Forti P; Department of Medical and Surgical Sciences (DIMEC) University of Bologna Bologna Italy., Maioli F; Geriatric Stroke Unit Medical Department Maggiore Hospital Bologna Italy., Arnone G; Geriatric Stroke Unit Medical Department Maggiore Hospital Bologna Italy., Coveri M; Geriatric Stroke Unit Medical Department Maggiore Hospital Bologna Italy., Pirazzoli GL; Department of Medical and Surgical Sciences (DIMEC) University of Bologna Bologna Italy., Zoli M; Department of Medical and Surgical Sciences (DIMEC) University of Bologna Bologna Italy., Procaccianti G; Neurology Stroke Unit Institute of Neurological Sciences (IRCCS) Maggiore Hospital Bologna Italy.
المصدر: Brain and behavior [Brain Behav] 2016 Apr 05; Vol. 6 (5), pp. e00460. Date of Electronic Publication: 2016 Apr 05 (Print Publication: 2016).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101570837 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-3279 (Electronic) NLM ISO Abbreviation: Brain Behav Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hoboken, NJ : John Wiley & Sons
مواضيع طبية MeSH: Outcome Assessment, Health Care*, Brain Ischemia/*blood , Homocysteine/*blood , Hyperhomocysteinemia/*blood , Stroke/*blood, Aged ; Aged, 80 and over ; Brain Ischemia/mortality ; Female ; Humans ; Hyperhomocysteinemia/mortality ; Male ; Stroke/mortality
مستخلص: Objectives: Plasma total homocysteine (tHcy) is a risk factor for ischemic stroke (IS) but its relationship with IS outcome is uncertain. Moreover, previous studies underrepresented older IS patients, although risk of both hyperhomocysteinemia and IS increases with age. We investigated whether, in elderly patients with acute IS, tHcy measured on admission to the Stroke Unit (SU) is an independent predictor of SU discharge outcomes.
Materials and Methods: Data are for 644 consecutive patients aged 80.3 ± 8.7 years, admitted to an Italian SU with diagnosis of acute IS. Plasma tHcy was measured on SU admission. Investigated outcomes included mortality during SU stay and poor functional status (modified Rankin Scale score ≥3) at SU discharge for survivors. The association of plasma tHcy with the study outcomes was assessed using Odds Ratios (OR) and their corresponding 95% confidence intervals (95%CI) from logistic regression models adjusted for demographics, pre-stroke features, IS severity, and laboratory data on SU admission (serum C-reactive protein, serum albumin, and renal function).
Results: Median plasma tHcy was 16.7 μmol/L (interquartile range, 13.0-23.3 μmol/L). Outcome incidence was 5.3% for mortality and 49.7% for poor functional status. Plasma tHcy was unrelated to mortality in both univariate and multivariable-adjusted analyses. Conversely, plasma tHcy was associated with poor functional status of survivors in univariate analyses (P = 0.014). Multivariable-adjusted analyses showed that, compared to normal homocysteinemia (tHcy <16 μmol/L), risk of being discharged with poor functional status significantly increased for moderate (tHcy ≥30 mol/L) but not mild (16.0-29.9 μmol/L) hyperhomocysteinemia.
Conclusions: In elderly patients with acute IS, high admission plasma tHcy is unrelated to mortality during SU stay but is an independent predictor of poor functional status at SU discharge in survivors. The association, however, is limited to patients with moderate hyperhomocysteinemia.
References: Neurology. 2013 Jan 1;80(1):29-38. (PMID: 23243075)
Eur J Biochem. 2001 Jul;268(14):3871-82. (PMID: 11453979)
Br J Nutr. 2010 Sep;104(6):893-9. (PMID: 20398433)
J Am Heart Assoc. 2012 Feb;1(1):42-50. (PMID: 23130117)
Stroke. 1984 May-Jun;15(3):492-6. (PMID: 6729878)
Neurology. 2011 Sep 6;77(10):965-72. (PMID: 21865573)
Diabetes Care. 2013 Jan;36 Suppl 1:S67-74. (PMID: 23264425)
Am J Clin Nutr. 2001 Jul;74(1):130-6. (PMID: 11451728)
Acta Neurobiol Exp (Wars). 2003;63(2):127-30. (PMID: 12926539)
Eur Neurol. 2010;64(5):304-10. (PMID: 21051895)
Nat Rev Neurol. 2010 May;6(5):256-65. (PMID: 20368741)
Cerebrovasc Dis. 2014;37(1):64-75. (PMID: 24401164)
Circulation. 2004 Jul 13;110(2):227-39. (PMID: 15249516)
Adv Nutr. 2012 Nov 01;3(6):755-62. (PMID: 23153729)
PLoS One. 2014 Sep 29;9(9):e107498. (PMID: 25265507)
J Am Soc Nephrol. 2005 Mar;16(3):763-73. (PMID: 15659562)
Acta Biochim Pol. 2010;57(4):467-77. (PMID: 21140003)
Neurol Sci. 2005 Dec;26(5):310-8. (PMID: 16388364)
Eur J Intern Med. 2013 Jun;24(4):362-7. (PMID: 23391475)
J Neurol. 2008 Jun;255(6):867-74. (PMID: 18338195)
Eur J Neurol. 2007 Jan;14(1):12-7. (PMID: 17222107)
J Chronic Dis. 1987;40(5):373-83. (PMID: 3558716)
BMC Neurol. 2008 Jul 12;8:26. (PMID: 18620594)
Bull World Health Organ. 1976;54(5):541-53. (PMID: 1088404)
Acta Neurol Scand. 2015 Jun;131(6):400-4. (PMID: 25307789)
Stroke. 1988 May;19(5):604-7. (PMID: 3363593)
Neurol Res. 2013 Nov;35(9):912-21. (PMID: 23816540)
Brain Behav. 2016 Apr 05;6(5):e00460. (PMID: 27096104)
Stroke. 1989 Jul;20(7):864-70. (PMID: 2749846)
Mol Neurobiol. 2013 Aug;48(1):157-68. (PMID: 23430482)
Stroke. 1993 Jan;24(1):35-41. (PMID: 7678184)
BMJ. 2009 Jan 08;338:a3083. (PMID: 19131384)
Mediators Inflamm. 2007;2007:15929. (PMID: 17597836)
Stroke. 2014 Mar;45(3):871-3. (PMID: 24448992)
فهرسة مساهمة: Keywords: Acute ischemic stroke; over 80 years oldstroke outcome; total homocysteine
المشرفين على المادة: 0LVT1QZ0BA (Homocysteine)
SCR Disease Name: Homocysteinemia
تواريخ الأحداث: Date Created: 20160421 Date Completed: 20171023 Latest Revision: 20210109
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC4828585
DOI: 10.1002/brb3.460
PMID: 27096104
قاعدة البيانات: MEDLINE